Organized by : Astellas
Synopsis : Multidisciplinary care is the cornerstone of optimal care for urothelial cancer patients. This masterclass aims to explore and discuss multidisciplinary collaborations between specialties, through clinical case sharing and panel discussions. There is emerging evidence around the management of urothelial cancer, from muscle-invasive bladder cancer to advanced/metastatic urothelial cancer. New treatment modalities such as antibody-drug conjugates and new combination therapies may re-define how urothelial cancer would be managed in the future.
Who should attend: Urologists, Uro-oncologists, Medical Oncologists, residents, trainees, pharmacists, nurses
Learning outcomes: Multidisciplinary approach towards patient care and latest advances in treatment options for urothelial cancer
| Time | Session |
|---|---|
|
15:30
15:50
|
|
|
15:50
16:15
|
Paradigm shifts and emerging therapies in Urothelial Cancer: MIBC to La/mUC continuum
|
|
16:15
16:40
|
Case Presentation 1: MIBC Cisplatin-eligible Panel Discussion
|
|
16:40
17:05
|
Case Presentation 2: MIBC Cisplatin-ineligible Panel Discussion
|
|
17:05
17:30
|
Case Presentation 3: MIBC bladder preservation Panel Discussion
|